glp-1 drug weight loss myths

semaglutide, tirzepatide, obesity treatment, prescription weight loss, GLP-1 / weight-loss drugs, GLP-1 receptor agonists — P

How GLP-1 Drugs Alter Prescription Weight Loss

GLP-1 drugs change prescription weight loss by slowing gastric emptying, boosting satiety signals, and enabling sustained calorie reduction. In 2026, a retrospective analysis of 20,542 obesity patients showed tirzepatide produced an average 4.7% greater weight loss than semaglutide after 20 weeks, highlighting dosing differences as a key factor.